These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5691599)

  • 1. Inhibition of diphenylhydantoin metabolism in rats and in rat liver microsomes by antitubercular drugs.
    Kutt H; Verebely K; McDowell F
    Neurology; 1968 Jul; 18(7):706-10. PubMed ID: 5691599
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and genetic factors regulating dilantin metabolism in man.
    Kutt H
    Ann N Y Acad Sci; 1971 Jul; 179():705-22. PubMed ID: 4105796
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of phenobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver microsomes.
    Kutt H; Haynes J; Verebely K; McDowell F
    Neurology; 1969 Jun; 19(6):611-6. PubMed ID: 5814306
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of isoniazid and its metabolites on phenytoin biotransformation in isolated rat hepatocytes.
    Noda H; Eto S; Minemoto M; Noda A; Ohno K
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):277-81. PubMed ID: 3594656
    [No Abstract]   [Full Text] [Related]  

  • 5. Isoniazid-induced inhibition in the biotransformation of [14C] diphenylhydantoin in rat.
    Buttar HS
    Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):35-57. PubMed ID: 905633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of diphenylhydantoin by rat liver microsomes. I. characteristics of the reaction.
    Kutt H; Verebely K
    Biochem Pharmacol; 1970 Mar; 19(3):675-86. PubMed ID: 4396252
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the endogenous metabolism of mycobacteria. 2. On the influence of enzyme inhibitors and effective antitubercular substances on 32 P-incorporation].
    Iwainsky H; Reutgen H; Kalich R
    Z Naturforsch B; 1968 Feb; 23(2):211-6. PubMed ID: 4385975
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro binding of (4-14C)diphenylhydantoin to rat brain microsomes.
    Hadfield MG; Bosworth JE
    Brain Res; 1974 May; 71(1):183-6. PubMed ID: 4821420
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of various antitubercular agents on the xylose resorption test].
    Bosseckert H; Stein G; Winnefeld K
    Z Gesamte Inn Med; 1971 Nov; 26(22):Suppl 22:309-1. PubMed ID: 5141037
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification by sodium salicylate and paraaminosalyicylic acid of the protein binding and antimycobacterial effect of isoniazid in vitro.
    Mattila MJ; Nieminen E; Vapaatalo HI; Brander E
    Arzneimittelforschung; 1972 Oct; 22(10):1769-71. PubMed ID: 4197739
    [No Abstract]   [Full Text] [Related]  

  • 11. Depression of prahydroxylation of diphenylhydantoin by antituberculosis chemotherapy.
    Kutt H; Winters W; McDowell FH
    Neurology; 1966 Jun; 16(6):594-602. PubMed ID: 5949235
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of isoniazid on the metabolism of 14C-diphenylhydantoin in rats.
    Buttar HS; Wong LT; Moffatt JH
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):9-18. PubMed ID: 736695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the variability of results of sensitivity determination in tuberculosis bacteria].
    Schmiedel A
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):238-47. PubMed ID: 4973009
    [No Abstract]   [Full Text] [Related]  

  • 14. [Heterogeneity of drug-resistant strains of Mycobacterium tuberculosis].
    Belogurova VP
    Probl Tuberk; 1970; 48(9):76-9. PubMed ID: 4996497
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum levels, urinary excretion, and side-effects of cycloserine in the presence of isoniazid and p-aminosalicylic acid.
    Mattila MJ; Nieminen E; Tiitinen H
    Scand J Respir Dis; 1969; 50(4):291-300. PubMed ID: 5380786
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentiation of bishydroxycoumarin in dogs by isoniazid and p-aminosalicylic acid.
    Eade NR; McLeod PJ; MacLeod SM
    Am Rev Respir Dis; 1971 Jun; 103(6):792-9. PubMed ID: 4103778
    [No Abstract]   [Full Text] [Related]  

  • 17. [Endocavernous treatment of caverns with atypical Mycobacteria].
    Neef W
    Z Erkr Atmungsorgane Folia Bronchol; 1970 Jun; 131(5):385-9. PubMed ID: 5210837
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
    Makarevich NM; Rudoĭ NM
    Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug sensitivity of the so-called atypical mycobacteria].
    Lucchesi M; Mancini P; Matzeu M
    Ann Ist Carlo Forlanini; 1968; 28(1):25-41. PubMed ID: 4314838
    [No Abstract]   [Full Text] [Related]  

  • 20. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
    Rudoĭ NM
    Probl Tuberk; 1974; (10):1-6. PubMed ID: 4213757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.